share_log

Matinas BioPharma | PRER14A: Preliminary revised proxy soliciting materials

SEC ·  Sep 24, 2019 04:32
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more